Navigation Links
MolecularHealth to Introduce Knowledge-Driven Solutions that Enhance Drug Safety and Enable Molecularly-Guided Treatment Decision Support

NEW YORK, Jan. 9, 2012 /PRNewswire/ -- MolecularHealth, a clinico-molecular informatics company, today announced the commercialization and planned roll-out of two next generation product lines that translate patient-specific molecular and genomic data, clinical history and published scientific evidence into safer, more effective drug choices for patients.

"With the cost of producing genomic information falling drastically and clinical data becoming increasingly accessible, today's remaining challenge resides in the analysis and interpretation of this information," said Friedrich von Bohlen, Ph.D., MolecularHealth's chief executive officer. "MolecularHealth has developed and is commercializing solutions that translate clinical and molecular data into actionable information, delivering precision medicine – safe and efficacious treatment decisions."

The company announced the planned commercial launch of two product lines in drug safety and molecularly-guided treatment decision support. Molecular Analysis of Side Effects (MASE) combines adverse event information with clinico-molecular knowledge about drug activity within a patient.

The company's molecularly-guided treatment decision support solutions, which will initially be available for use in oncology, integrate molecular data – including whole genome sequences – with clinical information about a patient, translating these data into evidence-based treatment strategies for marketed and clinical stage therapies.

"When we founded SAP forty years ago, we believed that organizing previously disaggregate data and systems could make for more efficient, effective enterprise resource planning," said Dietmar Hopp, co-founder and former Chairman and CEO of SAP and, through dievini Hopp BioTech, the sole investor in MolecularHealth. "Today, I see a similar opportunity in the healthcare sector, and MolecularHealth is paving the way through the integration of clinical and molecular information."

The company also announced the initiation of its U.S. commercial operations in New York under the leadership of Jeffrey D. Marrazzo, former executive with Generation Health, a genetic benefit management company.

"In the next five years, most cancer patients will have molecular and genomic profiles of their tumors," said Mr. Marrazzo. "MolecularHealth's mature technology platform and clinical and research relationships, including with the M.D. Anderson Cancer Center, will enable us to help physicians and other stakeholders translate this information into the language of the user."

In the coming months, the company will make a series of announcements critical to the advancement of precision medicine.

About MolecularHealthMolecularHealth is on the forefront of precision medicine, applying a pioneering approach called clinico-molecular informatics to patient treatment. The company's knowledge-driven solutions translate patient-specific molecular and genomic data, clinical history and published scientific evidence into safer and more effective drug choices. For patients at risk of a serious adverse drug event, or for those awaiting their next course of cancer treatment, precision matters. MolecularHealth's offerings range from a next generation drug safety assessment tool that analyzes the molecular basis of adverse events to the first oncology decision support solution that transforms whole genome sequencing data into evidence-based treatment strategies.

The company maintains offices in Basel, Switzerland; Heidelberg, Germany; Houston and New York and is backed by the co-founder, former chairman and chief executive officer of SAP, Dietmar Hopp. MolecularHealth has successfully built upon its heritage as one of the leading software analysis providers for the Human Genome Project. In 2008, MolecularHealth entered into a ten-year strategic affiliation agreement with The University of Texas M.D. Anderson Cancer Center to pursue joint research projects in the area of molecular medicine for the discovery, validation and/or development of biomarkers, drug targets, combinatorial treatments, alternative medical uses, adverse drug reactions or modes of action of drugs and other compositions. The company is led by a team of seasoned entrepreneurs, scientists and technologists, including founding members of Generation Health, LION Bioscience, Model N Life Sciences and Xapien.  Media Contacts

Corporate ContactTony Russo, Ph.D.

Eric M. StoneMatt Middleman, M.D.

Vice President, Sales and MarketingRusso Partners

T: (713) 834-9990T: 212-845-4251

eric.stone@molecularhealth.comT: 212-845-4272


SOURCE MolecularHealth
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. The Heart, Diabetes, And Weight Loss Centers of New York Introduce the New Science of Metabolic Diagnosis and Weight Management
2. Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children
3. Dr. Dello Russo Introduces the New EYE-Q Lasik
4. Caliper Life Sciences Introduces Drug Combination Services to Identify Synergistic Response of Compounds
5. Wedgewood Introduces Refresh(TM) Exchange-Program: Free Exchange of Expired Veterinary Compounded Medications Solves Key Industry Problem
6. CeloNova BioSciences Introduces a New Class of Coronary Stent: The CATANIA(TM) Coronary Stent System with NanoThin Polyzene(R)-F
7. Thermo Fisher Scientific Introduces Breakthrough in RNA-Interference Technology
8. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
9. Siemens Introduces New Standard of Care for Breast Ultrasound
10. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
11. Quest Diagnostics Introduces First Commercial Laboratory Test for Identifying the H1N1 Swine Flu Virus
Post Your Comments:
(Date:11/24/2015)... 1, a free mobile-first network that enables healthcare professionals ... new completely redesigned web version that includes uploading. The ... primarily on a desktop, to upload images directly from ... base, Figure 1 is hosting an event during the ... (RSNA) Annual Meeting. Joshua Landy , ...
(Date:11/24/2015)... WATERLOO, Ontario , Nov. 24, 2015 ... in digital X-Ray image sensing technology, will introduce its ... 2015 Technical Exhibition , November 29 to December 3, at ... portfolio of dynamic detectors for diagnostic and interventional imaging will ... Xineos family of advanced CMOS X-Ray detectors ...
(Date:11/24/2015)... , Nov. 24, 2015  NuShield, Inc., an industry leader in LCD screen protection and glare-elimination ... computer technology as part of their patient monitoring or electronic documentation system. ... ... ... A study in ...
Breaking Medicine Technology:
(Date:11/24/2015)... ... ... Autism Speaks, the world’s leading autism science and advocacy organization, will take ... of people around the world. On December 1, supporters can make an online donation ... the personal stories behind those gifts. , Just as Black Friday and Cyber-Monday ...
(Date:11/24/2015)... Tennessee (PRWEB) , ... November 24, 2015 , ... ... Pharmacy Quality Trend Report . Throughout the past year there have been multiple breakthroughs ... mature state. During this transition, PharmMD has enabled their customers and partners to stay ...
(Date:11/24/2015)... ... ... am so thrilled, as a newbie here, to leave a mark for the entire staff,” ... Makeover® from California Casualty . Stephanie is in her fifth year teaching at Santan ... , “This is such an amazing school and we deserve a space where we can ...
(Date:11/24/2015)... ... November 24, 2015 , ... Add a fresh touch to ... easy and affordable way to bring long-lasting style and cheer to any space. , ... clean the air and keep on giving all year long. , “Holiday plants make ...
(Date:11/24/2015)... ... November 24, 2015 , ... Tudore Tranquility is a new restaurant in Tokyo, ... plant-based fine dining menu that is full of flavorful and creative dishes that exceed ... wedding dinner or a small intimate event. The décor looks stunning with gold and ...
Breaking Medicine News(10 mins):